Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

…, G Kaplanski, MG Netea, E Pontali… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study

…, A Papavasileiou, MC Payen, E Pontali… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

[HTML][HTML] Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts

…, F Lipani, F Palmieri, A Sánchez-Montalvá, E Pontali… - Pulmonology, 2020 - Elsevier
Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim
of this study is to describe a group of patients who died with TB (active disease or sequelae) …

[HTML][HTML] Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and …

…, L Petrone, E Petruccioli, E Pontali… - European …, 2020 - Eur Respiratory Soc
Major epidemics, including some that qualify as pandemics, such as severe acute
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/…

[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

…, DM Cirillo, R Alagna, A Rendon, E Pontali… - International Journal of …, 2020 - Elsevier
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease

E Pontali, S Volpi, G Antonucci… - Journal of Allergy and …, 2020 - jacionline.org
7. Cron RQ, Chatham WW. The rheumatologist’s role in Covid-19. J Rheumatol 2020 Mar 24
[Epub ahead of print]. https://doi. org/10.3899/jrheum. 200334. 8. Arkatkar T, Du SW, Jacobs …

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

E Pontali, G Sotgiu, L D'Ambrosio… - European …, 2016 - Eur Respiratory Soc
The importance of adequately managing multidrug-resistant (MDR) and extensively drug-resistant
(XDR) tuberculosis (TB) cases for TB control and elimination are underlined in the …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

…, R Centis, L D'Ambrosio, E Pontali… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …

Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

E Pontali, G Sotgiu, S Tiberi… - European …, 2017 - Eur Respiratory Soc
The treatment of multidrug-resistant (MDR) or extensively drug-resistant (XDR) tuberculosis (TB)
remains a challenge for clinicians for several reasons, including the large number of …

New anti-tuberculosis drugs and regimens: 2015 update

L D'Ambrosio, R Centis, G Sotgiu, E Pontali… - ERJ Open …, 2015 - Eur Respiratory Soc
Over 480 000 cases of multidrug-resistant (MDR) tuberculosis (TB) occur every year globally,
9% of them being affected by extensively drug-resistant (XDR) strains of Mycobacterium …